STOCK TITAN

Jaguar Health, Inc. Announces Reverse Stock Split

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

Jaguar Health (JAGX) will carry out a 1-for-25 reverse stock split of its voting common stock on November 24, 2026. The split takes effect at 12:01 a.m. Eastern Time, and split-adjusted trading begins at market open that day. The shares will remain listed on the Nasdaq Capital Market under JAGX. Jaguar said the split is intended to support compliance with Nasdaq listing standards.

Shareholders approved the proposal at Jaguar's November 2026 special meeting. Every 25 shares will automatically become one share, with no change in par value per share. Holders who would otherwise receive a fractional share will receive cash instead. The post-split shares will have the security identifier (CUSIP) 47010C839. Jaguar filed its definitive proxy statement for the meeting on October 8, 2026.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.1-for-25 reverse stock split takes effect November 24, 2026, to support compliance with Nasdaq listing standards.

Key Figures

Reverse split ratio: 1-for-25 Effective date: November 24, 2026
Reverse split ratio
1-for-25
Exchange ratio for issued and outstanding voting common stock
Effective date
November 24, 2026
Effective at 12:01 a.m. Eastern Time

Previous Stock split Reports

3 past events · Latest: Sep 15
Same Type 3 events
  1. Sep 15

    Reverse split

    24h Move
    -29.6%

    Announced a 1-for-15 reverse split to support Nasdaq listing-standard compliance.

  2. Apr 27

    Reverse split

    24h Move
    -27.8%

    Announced a 1-for-35 split alongside a Nasdaq extension to demonstrate bid-price compliance.

  3. Mar 18

    Reverse split

    24h Move
    -47.8%

    Announced a 1-for-25 split to support Nasdaq listing compliance, approved at a special meeting.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

reverse stock split, cusip, par value, street name
4 terms
reverse stock split financial
"will effect a reverse stock split of its issued and outstanding voting common stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
cusip technical
"The new CUSIP number for the Company's Common Stock following the reverse stock split"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
View in glossary
par value financial
"without any change in the par value per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
street name financial
"shares in brokerage accounts or "street name""
A "street name" is a way that stocks or other financial assets are registered under a broker's name rather than directly in an individual investor's name. This allows for easier buying, selling, and transferring of the assets, much like how a library might hold books on behalf of many readers. For investors, using a street name simplifies transactions and helps maintain privacy, but it also means the broker is the official record holder of ownership.
View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SAN FRANCISCO, CA / ACCESS Newswire / November 20, 2026 / Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock ("Common Stock"), at an exchange ratio of 1-for-25, at 12:01 am Eastern Time on Tuesday, November 24, 2026 (the "Effective Date") in order to support the Company's compliance with Nasdaq's listing standards. The Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol "JAGX". The new CUSIP number for the Company's Common Stock following the reverse stock split is 47010C839.

The effectuation of the reverse stock split follows the approval of a proposal submitted to Jaguar stockholders at the Company's November 2026 Special Meeting of Stockholders (the "Special Meeting"). This proposal is described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting filed with the Securities and Exchange Commission (the "SEC") on October 8, 2026. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at http://www.sec.gov. The proxy statement is also available on the Company's corporate website.

When the reverse stock split becomes effective, every twenty-five (25) shares of the Company's Common Stock immediately prior to the Effective Date shall automatically be reclassified into one (1) share of Common Stock, without any change in the par value per share, and this change will be reflected on Nasdaq's website and other stock quote platforms. No fractional shares will be issued as a result of the reverse stock split. Stockholders who otherwise would be entitled to receive a fractional share in connection with the reverse stock split will receive a cash payment in lieu thereof.

Equiniti Trust Company, LLC is acting as exchange agent for the reverse stock split and will send instructions to stockholders of record who hold stock certificates regarding the exchange of their certificates for post-reverse stock split shares of Common Stock. Stockholders who hold their shares in brokerage accounts or "street name" are not required to take any action to effect the exchange of their shares.

About the Jaguar Health Family of Companies

Jaguar Health, Inc. ("Jaguar") develops novel proprietary prescription drugs sustainably derived from plants for people with complicated gastrointestinal ("GI") disease states. Jaguar family companies Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A. focus on the development and commercialization of novel crofelemer powder for oral solution for the treatment of rare and orphan gastrointestinal disorders with intestinal failure, including microvillus inclusion disease and short bowel syndrome. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

For more information about:

Jaguar Health, visit https://jaguar.health

Napo Pharmaceuticals, visit napopharma.com

Napo Therapeutics, visit napotherapeutics.com

Magdalena Biosciences, visit magdalenabiosciences.com

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements." These include statements regarding Jaguar's expectation that the Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

hello@jaguar.health

Jaguar-JAGX

SOURCE: Jaguar Health, Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the Jaguar Health (JAGX) reverse split ratio, and when does it take effect?

Jaguar Health's 1-for-25 reverse split takes effect at 12:01 a.m. Eastern Time on November 24, 2026. Split-adjusted trading begins at market open that day.

Do Jaguar Health shareholders need to do anything for the JAGX reverse split?

Shareholders who hold JAGX through a brokerage do not need to take any action. Equiniti Trust Company, the exchange agent, will send instructions to shareholders of record who hold stock certificates.

Keep reading